About Us

by diabetalabs
June 23, 2023

DBL Members Co-Author Publication on the Promise of Multiagonist Peptide Therapies for Obesity

Following the recent approval of GLP-1R (glucagon-like peptide-1 receptor) agonist therapies for the pharmacological management of […]
0
read more
by diabetalabs
June 23, 2023

DBL’s Novel Approach to Diabetes Management Highlighted by The Irish Times

Dia Beta Labs’ CEO, Dr. Ryan Lafferty, took the opportunity to sit down with Barry McCall, […]
0
read more